c blocker Dosa ge: 50 mg HS Indication: Management of manifestatio ns of psychotic disorders; control of manic phase of manic depressive illness. Control nausea, vomiting, and intractable hiccups. Relief of restlessness & apprehension before surgery. Acute intermittent porphyria therapy. Adjunct in Contraindication: Comatose states Presence of large amounts of CNS depressants. Presence of bone marrow depression Hypersensitivit y. Adverse/Side Effects: Adverse effects: Drowsiness, insomnia, vertigo, headache, weakness, tremors, ataxia, slurring, cerebral edema, extrapyramida l syndromes, neuroleptic malignat syndromes, aplastic anemia, blurred vision, dry mouth and urinary retention. Side effects: Drowsiness, sensitivity to sun, pink or Nursing Responsibi lities: Assess mental status prior to and periodically during therapy. Monitor BP and pulse prior to and frequently during the period of dosage adjustment. May cause QT interval changes on ECG. Observe patient carefully when administerin g medication,
to ensure that medication is actually taken and not hoarded. Monitor I&O ratios and daily eight. Assess patient for signs and symptoms of dehydration. Monitor for developmen t of neuroleptic malignant syndrome (fever, respiratory distress, tachycardia, seizures, diaphoresis, hypertensio n or hypotension , pallor,
tiredness, severe muscle stiffness, loss of bladder control. Report symptoms immediately . May also cause leukocytosis , elevated liver function tests, elevated CPK. Caution the cardiac disease Adverse effects: Drowsiness, client that or dizziness, the hypertension, sedation, medication glaucoma, disturbed may cause gastric or coordination, drowsiness, duodenal ulcers fatigue, confusion, creating hypotension, difficulties Allergy to palpitations, or hazards antihistamine, bradycardia, or other third trimester tachycardia, activities of pregnancy epigastric distress, that require and lactation.
Antihistamin e Antiparkinso nian Anti-motion sickness drug Cough suppressant Sedative hypnotic
50 mg/ca p HS PRN
Parkinsonism (including drug induced parkinsonism and extrapyramid al reactions) in the elderly intolerant of more potent drugs and in combination
with centrally acting anticholinergi c antiparkinson ian drugs. Relief of symptoms associated with perennial and seasonal allergic rhinitis; vasomotor rhinitis; allergic conjunctivitis, Active and prophylactic treatment of motion sickness night time sleep aid
haemolytic anemia, hypoplastic anemia, thrombocytopenia, leukopenia, agranulocytosis, pancytopenia, and thickening of bronchial secretions. Side effects: Dizziness, sedation, drowsiness, epigastric distress, diarrhea or constipation, dry mouth, thickening of bronchial secretions and dryness of nasal mucosa.
alertness. Tell the client to take the medication with food to decrease GI upset. Explain to the client that arising quickly forms a lying or sitting position may cause orthostatic hypotension . When taking these medications, the client needs to have blood cells counts,
renal function, hepatic function, and blood pressure monitored. Adverse effects of these drugs occur more commonly in elderly clients. Explain to the client that use of these drugs in warm weather may increase the likelihood of heatstroke. Generic name: Antipsychotic Dopaminergic Adverse effects: somnolence, Inspect I.M. solution for
Treatment of schizophrenia
Zydis
Acute mixed or manic episodes associated with bipolar 1 disorder and maintenance of bipolar 1 disorder as monotherapy or combined with lithium or valproate Agitation associated with schizophrenia and bipolar 1 mania (injection)
olanzapine, myeloproliferative disorders, severe CNS depression, comatose states, and lactation.
dizziness, nervousness, headache, akathisia, personality disorders, tardive dyskinesia, neuroleptic malignant syndrome, orthostatic hypotension, peripheral edema, tachycardia, constipation, abdominal pain, cough, pharyngitis, Side effects: Drowsiness, dizziness, sedation, seizures, increased salivation, constipation and fast heart rate.
particulate matter and discoloration before administration. Encourage patient to void before taking the drug to help decrease anticholinergic effects of urinary retention. Monitor for elevations of temperature and differentiate between infection and neuroleptic malignant syndrome. Monitor for orthostatic hypotension and provide appropriate safety measures
as needed. Monitor patient regularly for signs and symptoms of diabetes mellitus; monitor lipid and triglyceride levels. Peel back foil on blister pack of disintegrating tablets; do not push through foil; use dry hands to remove tablet, place entire tablet in mouth. If to be given as analgesia, assess onset, type, location, duration of pain.
Antipyretic, analgesia
500 mg
Stimulation, drowsiness, nausea, vomiting, abdominal pain, hepatotoxicity, Can be given rash and without regards urticaria. to meals.
Assess temperature directly before and 1 hour after giving medication. If respirations are <12/min (<20/min in children), withhold the medication and contact the physician. Generic name: Brand name: